Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin

Objectives The palliation of patients with malignant bile duct obstruction using metal or plastic biliary stents may be limited by stent occlusion. The aim of this study was to determine the safety and efficacy of endoscopically delivered meso-tetrahydroxyphenyl chlorin photodynamic therapy in the treatment of irresectable malignant biliary strictures and recurrent stent occlusion. Methods Thirteen patients with malignant biliary obstruction owing to carcinoma of the biliary tract (n=9), pancreas (n=3) or stomach (n=1), were studied. All had been initially palliated with metal (n=10) or polyethylene (n=3) biliary stents, but presented with recurrent obstructive jaundice because of local tumour progression. Patients received meso-tetrahydroxyphenyl chlorin 0.15 mg/kg intravenously 72 h before endoluminal light activation with an endoscopically placed optical fibre, followed by polyethylene stent insertion. Results Before photodynamic therapy, patients had a median of three (range 0–5) stent occlusions in the preceding 11 (2–22) months, with a median patency of plastic stents placed inside metal bile duct stents for recurrent stent occlusion of 3.5 (0.5–13) months. After photodynamic treatment, tumour necrosis and/or metal stent recanalization was seen in all patients, with a median of 0 (0–3) stent occlusions during 7 (1–43) months follow-up. The median patency of plastic stents placed inside metal stents after photodynamic therapy was 5 (1–43) months. The median survival after diagnosis and photodynamic therapy administration was 21 (10–56) and 8 (1–43) months, respectively. Photodynamic therapy was generally well tolerated but two patients developed cholangitis within the first week, complicated in one by a fatal liver abscess and two developed haemobilia within 4 weeks of treatment, one of whom died with a gall bladder empyema. Conclusion In patients with malignant biliary obstruction, endoscopically delivered meso-tetrahydroxyphenyl chlorin photodynamic therapy causes efficient tumour necrosis and recanalization of blocked metal stents, but there is a significant risk of complications.

[1]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.

[2]  D. Apel,et al.  Photodynamic therapy for palliation of nonresectable bile duct cancer—preliminary results with a new diode laser system , 2001, American Journal of Gastroenterology.

[3]  B. Petersen,et al.  Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: An evidence-based approach. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  R. Mondragón-Sánchez,et al.  Haemobilia and gallbladder carcinoma. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  L. Nyhus,et al.  Hemobilia: review of recent experience with a worldwide problem. , 1987, The American journal of gastroenterology.

[6]  T. Ponchon,et al.  A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. , 1998, Gastrointestinal endoscopy.

[7]  T. Sauerbruch,et al.  Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. , 2003, Gastrointestinal endoscopy.

[8]  Paul M. Ripley,et al.  Photodynamic therapy for cancer of the pancreas , 2002, Gut.

[9]  J Moan,et al.  Evaluation of a new photosensitizer, meso‐tetra‐hydroxyphenyl‐chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers , 1994, International journal of cancer.

[10]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[11]  G. Gores,et al.  Endoscopic application of photodynamic therapy for cholangiocarcinoma. , 2000, Gastrointestinal endoscopy.

[12]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[13]  R. Higuchi,et al.  A patient with undifferentiated carcinoma of gallbladder presenting with hemobilia , 2000, Journal of Gastroenterology.

[14]  P. Kortan,et al.  Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. , 1996, Gastrointestinal endoscopy.

[15]  H. Thomas,et al.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.

[16]  R. Kurtz,et al.  Endoscopic management of occluded biliary Wallstents: a cancer center experience. , 2003, Gastrointestinal endoscopy.

[17]  J. Pausch,et al.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. , 1993, Endoscopy.

[18]  H. Bismuth,et al.  Management strategies in resection for hilar cholangiocarcinoma. , 1992, Annals of surgery.

[19]  G. Minoli,et al.  Photodynamic therapy of nonresectable cholangiocarcinoma , 1999 .

[20]  G. Tytgat,et al.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction , 1992, The Lancet.

[21]  N. Aronson,et al.  Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies. , 2002, Gastrointestinal endoscopy.

[22]  Helen Hickey,et al.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.

[23]  M. Christian,et al.  Measuring response in solid tumors: unidimensional versus bidimensional measurement. , 1999, Journal of the National Cancer Institute.

[24]  A. Goetz,et al.  Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. , 2000, Journal of hepatology.

[25]  U. Mansmann,et al.  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. , 2003, Gastroenterology.

[26]  A. Tannapfel,et al.  Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival , 2000, Hepatology.

[27]  Thierry Ponchon,et al.  Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. , 2003, Gastrointestinal endoscopy.

[28]  P J Kumar,et al.  The Exocrine Pancreas. , 1980 .

[29]  F. Halter,et al.  Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. , 1996, The American journal of gastroenterology.

[30]  Stephen P. Pereira,et al.  Photodynamic therapy for pancreatic and biliary tract carcinoma , 2009, BiOS.

[31]  K. Mergener,et al.  Photodynamic therapy for malignant tumours of the ampulla of Vater. , 1997, Gastrointestinal endoscopy.

[32]  S. Williams,et al.  The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. , 1997, Endoscopy.

[33]  J. van Dam,et al.  Management of occluded biliary Wallstents , 1998, Gut.

[34]  A. Schärli.  Extrahepatic bile ducts , 1992, Pediatric Surgery International.